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The  bactericidal capacity of  normal serum has  been of  interest since the  early 
studies  of  Metchnikoff on  the  inflammatory response.  A  heat-stable  bactericidal 
system in animal serum, active against Gram-positive organisms, was first described 
in 1887 by Fodor (1). This activity was named beta lysin, to distinguish it from the 
alpha lysin or heat-labile antibacterial system involving  complement. Gengou, in 1901, 
demonstrated that  the heat-stable bactericidal activity was cell  derived (2).  When 
rabbit blood was  drawn into chilled,  paraffin-lined tubes to  delay clotting and all 
cellular elements were  removed by centrifugation before  the  cell-free  plasma  was 
allowed to clot, the serum so produced did not kill bacteria. Serum from clotted whole 
blood, on the other hand, was strongly bactericidal. The interpretation of this phe- 
nomenon was that cells, probably leukocytes, were responsible for the generation of 
bactericidal activity. 
Several lines of evidence have since implicated platelets rather than leukocytes or 
erythrocytes as  the cellular source of  the beta lysin bactericidal activity. In 1960 
Hirsch  extended  Gengou's experiments by  reporting that  the  development of  the 
heat-stable bactericidin in rabbit serum required the presence only of blood platelets 
during clotting of the cell-free plasma; addition of other types of blood cells did not 
contribute to the bactericidal effect (3).  Saline extracts of platelets, however, did not 
have any antibacterial activity. Hunder and Jacox  demonstrated that serum from 
rabbits made thrombocyopenic by X-irradiation or by administration of antiplatelet 
serum had  a  markedly decreased  bactericidal capacity  (4).  Jago  and Jacox  found 
that two components were necessary for serum bactericidal activity (5). One was re- 
leased from platelets by homogenization in saline, but the second was released only 
after  sonication. They  noted  that  these  components were  relatively heat  stable. 
Myrvik and Leake described extraction of two serum components from rabbit serum 
by precipitation with low concentrations of ethanol, a procedure which precipitates 
basic proteins (6). The two components together, but not separately, were bactericidal. 
Basic proteins present in lysosomal granules of rabbit polymorphonuclear  leukocytes 
have  been shown  to  participate in inflammatory responses  as  bactericidal and as 
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permeability-enhancing factors  (7,  8). Normal human platelets contain similar basic 
proteins which are not bactericidal but are associated with enhancement of vascular 
permeability (9). Rabbit platelets have not been studied previously for their content 
of basic proteins. 
The  studies  reported  here  were  designed  to  determine  whether  the  heat- 
stable  bactericidal  activity of rabbit  serum is related  to platelet  cationic  pro- 
teins.  Our  observations  indicate  that  cationic  proteins  which  are  present  in 
platelet  lysosomal  granules  have  bactericidal  activity.  These  proteins  are  re- 
leased from  the  platelets  during  the  process  of aggregation  and  represent  the 
source of the rabbit  serum bactericidin. 
Materials  and Methods 
Preparation  of Rabbit  Platelet Acid Extract.-- Healthy, outbred, adult New Zealand White 
rabbits were used for all studies.  Rabbits were bled from the ear artery by plastic cannula 
(Medicut, A. S. Aloe Co., St. Louis, Mo.) into plastic  tubes  containing 0.1  vol of 3.8%  tri- 
sodium citrate.  Platelet-rich plasma  (PRP) I was separated by centrifugation at 250 g for 30 
rain at room temperature in an International model UV centrifuge (International Equipment 
Company,  Needham Heights, Mass.),  and  the platelets were sedimented from the PRP in 
siliconized  oil bottles by centrifugation at 1000 g for 30 min at room temperature. Contamina- 
tion of platelets by leukocytes was less than  1 cell/104 platelets. The platelet buttons were 
pooled and washed six times in Alsever's solution and four times in Gaintner buffer.  Washed 
platelets were resuspended  in 4  vol of 0.2  •  H2SO4  and  stirred overnight at 4°C, or were 
sonicated for 30 sec in normal saline using a  Branson sonifier  (Branson Instruments,  Inc., 
Stamford, Conn.)  (4 amp, setting 4) before acid extraction. The rabbit platelet acid extract 
(RPAE) was dialyzed against 0.01 M phosphate-buffered normal saline at pH  5.6 before use 
in bacteriologic assays.  For preparation of subcellular fractions, washed platelets  were sus- 
pended in 0.44 ~  sucrose  containing 0.001 ~t ethylenediaminetetraacetate  (EDTA), homoge- 
nized in the cold, and subjected to sucrose density gradient ultracentrifugation by the method 
of Marcus et al.  (10). All preparations  were sterilized by filtration  through  a  0.45 ~  pore 
membrane filter (Millipore Corp., Bedford, Mass.) before use. 
Bactericidal Assay.--Bacillus subtilis was grown for 18 hr at 37°C with shaking in Trypticase 
soy broth (Baltimore Biological Laboratories, Baltimore, Md.) containing lVfv  added dextrose. 
The bacteria were collected by centrifugation and  resuspended  in 0.15  •  saline containing 
0.1%  bovine serum albumin  (Pentex Biochemical, Kankakee,  Ill.).  A  stock suspension  of 
bacteria was prepared by adjustment to an optical density at 650 nm of 0.270,  and a  1 : 1000 
dilution in saline-albumin solution was used to inoculate test samples. Platelet acid extract 
dialyzed  against  buffered  saline  was  serially diluted  in  saline-albumin  solution  in  sterile 
plastic test tubes.  After inoculation with B. subtilis  the tubes were incubated at 37°C with 
mixing on a Lab Tek aliquot mixer (Ames Co., Inc., Elkhart, Ind.)  for 1 hr. Aliquots were 
then pipetted into Petri dishes and pour plates were made with melted Trypticase soy agar. 
Surviving colonies were counted after overnight incubation. Duplicate samples agreed within 
10%. A 50% reduction in bacterial colony count was considered significant killing. 
Ptatelet Aggregation.--Aggregation  was tested in two systems: in platelet-rich plasma and 
in suspensions  of washed platelets. Fresh, citrated,  rabbit platelet-rich plasma was adjusted 
1 Abbreviations  .used in this paper: PF 4, platelet factor 4; PPP, platelet-poor plasma; PRP, 
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to a platelet count of 500,000/mm 3 with platelet-poor plasma  (PPP).  Rabbit platelets were 
washed  three  times in  Alsever's solution at  room  temperature  and  resuspended  in  Gey's 
buffered salt solution, pH 7.0, containing 0.35%  bovine albumin and  1% dextrose.  Soluble 
collagen  2 (11) (4 mg/ml in 0.5 M CaC12), bovine thrombin (Parka, Davis & Company, Detroit, 
Mich.), and adenosine diphosphate  (ADP)  (Pabst Research Laboratories, Milwaukee, Wis.) 
(2  X  10  -6 ~) were added to 1.2-ml samples of the platelet preparations and aggregation was 
observed and recorded on an Aggregometer (Chronoqog Corp., Broomall, Pa.). Immediately 
after aggregation of the platelet preparation, the supernatant was separated by centrifugation 
at 1000 g and either assayed for bactericidal activity directly or extracted with 0.2 N H2SO4 
and then assayed. 
Platdet Factor 4 Assay.--Antiheparin  activity (platelet factor 4) of the platelet extract was 
measured  using the  thrombin clotting time method  of Poplawski  and  Niewiarowski  (12). 
The test system comprised 0.3 ml fresh citrated rabbit PPP, 0.1 ml saline or platelet extract, 
0.1 ml heparin (0.2 units/ml). 0.1 ml of bovine thrombin (10 units/ml) was added and clotting 
time was  recorded  during  mixing at  37°C.  Heparin  concentration was  selected to yield a 
clotting time at  least  three  times that  of a  saline-PPP  control.  Partially purified platelet 
factor 4 was prepared by the zinc acetate precipitation method of Niewiarowski et al.  (13). 
Characterization and  Purification of Rabbit Platelet Acid  Extract.--Rabbit  platelet  acid 
extract dialyzed against 0.02 •  sodium acetate buffer, pH 6, was applied to diethylaminoethyl 
(DEAE)  cellulose columns  equilibrated  with the same  buffer.  In some studies  the  buffer 
system included 0.05 M NaC1.2-ml fractions were collected with a  Buchler fraction collector 
(Buchler Instruments, Inc., Fort Lee, N. J.) equipped with an LKB Uvicord recorder (LKB 
Instruments, Inc., Rockville, Md.). For elution, a gradient of 0-0.5 ~ NaC1 in 0.02 •  sodium 
acetate buffer, pH 6, was applied. Samples of representative fractions were adjusted to pH 5.6 
with 0.01 ~ NaOH, sterilized by filtration, and assayed for bactericidal activity and for platelet 
factor 4 activity. The active material from the DEAE columns was concentrated, by ultra- 
filtration  and  subjected  to  gel  filtration  on  G-75  Sephadex  (Pharrnacia  Fine  Chemicals, 
Uppsala, Sweden).  The molecular weight of effluent  peaks was estimated by protein markers 
of known molecular weight. Active fractions were concentrated and analyzed by acrylamide 
gel electrophoresis using the Reisfeld buffer system (14). 
Assay for lysozyme was performed by radial diffusion of RPAE in agar containing non- 
viable Micrococcus lysodeikticus, using  normal  serum  containing  known  concentrations  of 
lysozyme as control. Pepsin digestion of the RPAE was performed according to the method of 
Bailey et al. (15). 
RESULTS 
The protein fraction extracted from washed rabbit platelets by dilute H2SO4 
killed Bacillus subtilis  suspended  in  saline-albumin  solution.  The  bactericidal 
activity was directly related to the protein  concentration  of the RPAE  (Table 
I).  Concentrations  of 0.5/zg protein/ml,  or greater,  killed more  than  50%  of 
the  bacterial  inoculum  (1  X  103-5  X  105  organisms/ml).  Although  different 
preparations  of rabbit platelet extracts varied in bactericidal activity, all dem- 
onstrated  a  similar range with greater than  90 %  killing at  concentrations  of 5 
/~g/ml. 
Species sensitive to the bactericidal  effect of RPAE  included  several strains 
of Staphylococcus  albus  and  one  strain  of S.  aureus  (giorgio).  Gram-negative 
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organisms  tested  (Escherichia  coli  and Salmonella  newport),  as  well  as  most 
strains of S. aureus, were not susceptible to killing by RPAE. The bactericidal 
spectrum of RPAE  is essentially the same as that reported for rabbit serum 
by Hirsch (3). 
The bactericidal effect of the RPAE  was rapid  (Fig.  1).  Significant killing 
of stationary-phase cultures (18 hr growth) occurred within 30 min of incuba- 
tion of bacteria with RPAE and was complete after 90 rain. The rates of kill- 
ing were similar at  concentrations  of 102-105 bacteria/#g  of platelet protein. 
The  fraction  of  bacteria  surviving  was  slightly  greater  with  larger  inocula. 
Bacteria in the logarithmic phase of growth (4 hr) were killed more completely 
and  rapidly than bacteria from stationary-phase cultures,  with  greater  than 
90% killing achieved by 10 rain exposure. The bactericidal effect of the RPAE 
TABLE I 
Bactericidal Activity of Rabbit Platdet Acid 
Extract Rdated to Protein 
Concentration 
/zg protein/ml  % colonies  surviving* 
10  4 
5  10 
2.5  13 
1.25  23 
0.6  48 
0.3  69 
0.15  95 
* 1 hr incubation at 37°C. 
demonstrated  temperature  dependence  (Table II).  The  maximal killing  oc- 
curred when incubation with RPAE was carried out at 37°C. Cold was inhibi- 
tory, with more than 16 times as much RPAE necessary to produce significant 
killing at 4°C. The bactericidal activity was adsorbed from the platelet extract 
by exposure to  high  concentrations  of heat-killed  bacteria  (Table III). The 
bacteria were not agglutinated by the RPAE. 
Platelet-free rabbit plasma, clotted to form serum, had no significant bac- 
tericidal activity when diluted  more than  1:5  (Fig.  2). Normal rabbit serum 
prepared from whole blood was bactericidal at dilutions of 1:40-1:80.  RPAE 
contained  from 5  to  10 #g  of protein/ml  extracted  from rabbit  serum.  The 
addition of 1-20/zg RPAE protein/ml to diluted serum prepared from platelet- 
free plasma restored  the bactericidal  activity found in normal rabbit serum. 
The bactericidal  capacity of the  RPAE  was neither  enhanced  nor inhibited 
in the presence of serum. 
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ity of the RPAE was nondialyzable (Table III). The activity was optimal over 
the  pH range  of 5.6-7.2.  Bacterial  growth was itself  inhibited  by incubation 
at more acid or alkaline pH conditions. The biologic activity of the RPAE was 
stable  to heating  to 56°C for 30 rain  or to 80°C for  15  min  but activity was 
lost after prolonged boiling. RPAE retained full activity for prolonged periods 
100 
80 
5  60 
'~  4C 
EL 
eA 
AB 
oC 
oF 
30  60 
Incubation time (min) 
90 
FIo.  1.  Bactericidal  effect of rabbit  platelet  acid  extract  as  a  function  of incubation 
period.  Colonies  of B. subtilis surviving 5, 30, 60, and 90 rain incubation with RPAE at 37°C 
at different bacterial concentrations. A, 3 X 108 bacteria/ml;  B, 6 X 10  ~ bacteria/ml;  C, 1 X 
1@ bacteria/ml;  D, 1.5  X  10  ~ bacteria/ml;  E, 6 )<  104 bacteria/ml.  RPAE concentration,  5 
#g/ml. 
when kept at low pH (in dilute H2SO~) but activity was lost rapidly upon stor- 
age at alkaline  pH and at low ionic strength,  e.g. when dialyzed against 0.01 
1~ sodium phosphate  buffer without  saline,  or when  dialyzed against  distilled 
water. In the presence of 0.15 u  NaC1 activity was retained during storage at 
-20°C  for several  weeks.  Pepsin  digestion  resulted  in  complete  loss  of bac- 
tericidal activity. No lysozyme could be demonstrated in the RPAE. 
Bactericidal activity was precipitated from the RPAE by addition of ethanol 
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demonstrated bactericidal activity against B. subtilis at a  concentration of 0.3 
#g protein/ml. 
Heparin inhibited  the bactericidal  effect of RPAE at concentrations  as low 
as  0.1  unit//~g  of platelet  protein  (Table  IV).  The  concentration  of  RPAE 
used in the heparin inhibition  experiments was  17  times that required  to pro- 
duce 90 %  bacterial killing. RPAE excess was utilized in these studies in order 
TABLE II 
Effect of Incubation Temperature on 
Bactericidal Activity  of Rabbit 
Platdet  Acid  Extract 
Incubation temperature  % activity 
37°C  100 
25°C  25 
4°C  6 
TABLE III 
Properties of Platelet Bactericidal Protein 
Treatment of RPAE  Bactericidal 
activity 
Dialysis vs. 0.01 ~ phosphate-0.15  M NaC1, pH 5.6 (control) 
Dialysis vs. 0.01 ~ phosphates0.15 M NaC1, pH 7.2 
Dialysis vs. 0.01 ~ phosphate,  no saline, pH 7.2 
Dialysis vs. H20 
Dialysate,  concentrated 
Heating to 80°C, 15 min 
Heating to 100°C, 30 rain 
Pepsin  (0.2%) digestion 
Exposure to 108 killed B. subtilis/inl 
% control 
100 
100 
6 
10 
0 
100 
0 
0 
0 
to  emphasize  the  marked  inhibition  of  bactericidal  activity  by  polyanionic 
heparin. 
Subcellular  Localization  of  Bactericidal  Material.-Platelet  granules  were 
separated from other components of homogenized platelets by sucrose density 
gradient ultracentrifugation. Acid extracts of the granule fraction demonstrated 
strong  bactericidal  activity  (Table  V).  The  membrane  fraction  was  inactive 
even at high protein concentration. 
Release  of  Bactericidal  Activity  During  Platelet  Aggregation.--Bactericidal 
activity was released  when rabbit platelets  were aggregated in citrated  plate- 
let-rich  plasma.  Washed  platelets  suspended  in  buffered  saline  also  released 
bactericidal  activity  after  aggregation  by collagen  (Fig.  3).  The  bactericidal 1120  RABBIT PLATELET BACTERICIDAL PROTEIN 
material  appeared in the supernatant  plasma  or saline after sedimentation  of 
the aggregated platelets.  Some bactericidal activity was present in low dilutions 
of  platelet-poor  plasma  after  centrifugation,  probably  reflecting  mechanical 
damage  to  and  release  from platelets  during  the  centrifugation procedure. 
3000 --  O 
-Serum  (no platelets) 
/  / 
/ 
200C -- 
/ 
I OOC  / 
/ 
400 
g 
200 
Serum  (platelets)-. 
Serurn (no platelets] 
+ platelet extract 
70~20 
Reciprocal  of dilution of factor tested 
Fzo.  2.  Bactericidal activity of normal rabbit serum prepared from platelet-free plasma, 
and  rabbit platelet  acid  extract.  Bacteria surviving incubation with:  0--0,  dilutions of 
normal rabbit serum; O--O,  dilutions of serum prepared from platelet-free plasma; /x--/x, 
dilutions of RPAE, 120 #g/ml, in the presence of platelet-free serum. 
TABLE  IV 
lYeparln  Inhibition  of Bactericidal  Activity of 
Rabbit Platdet Acid Extract 
Heparin  % colonies  surviving* 
units~rag 
0  4 
0.1  11 
1.0  40 
10.0  100 
* Incubation 1 hr at 37°C using RPAE, 8 #g/ml. B.  B.  WEKSLER  AND  R.  L.  NACHMAN 
TABLE  V 
Subcdlular Localization  of Bactericidal  Activity within Platdets 
1121 
Platelet fraction  Protein 
concentration 
Surviving colonies of B. subtiIis 
No.  Control  of colonies  %survival 
Granule 
Membrane 
#g/mt 
10  2  701 
90  632  701 
0.3 
90.1 
10C -- 
8C 
"~ 
5  6c- 
t~ 
~'  4( 
2O 
[  I  ~  I  I 
1:10  1:20  1:40  1:80  1:160 
Diluti0n of supernatant 
FzG. 3.  Release  of  bactericidal  activity  from  platelets  during  aggregation,  survival of 
bacteria after incubation with dilutions of supernatant plasma or saline after platelet aggrega- 
tion by collagen,  and  sedimentation of platelets  at  1000  g.  Lk--/k,  platelet-p06r plasma; 
A--A,  platelet-rich plasma (500,000  platelets/mm  8) plus 0.4 mg collagen; ©--O, platelet- 
rich plasma and aspirin  (1 mg/ml) plus 0.4 mg collagen;  Q--Q,  platelet-rich plasma and 
imipramine (1.25 mg/ml) plus 0.4 mg collagen; C)  ....  ©, washed platelets in Gey's solution 
plus collagen, 0.4 rag. 
Aggregation inhibitors such as imipramine and aspirin significantly  decreased 
the release  of bactericidal activity from platelets exposed to aggregating doses 
of collagen (Fig. 3). Acid extracts of the supernatant fluid remaining after sedi- 
mentation of aggregated platelets retained the bactericidal activity. 1122  RABBIT  PLATELET  BACTERICIDAL  PROTEIN 
Collagen-induced  platelet  aggregation  released  bactericidal  activity  from 
platelets in proportion to the concentration of collagen used (Fig. 4). The upper 
panel of Fig. 4 depicts the aggregation curves recorded by the platelet  Aggre- 
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FIG. 4.  Release  of bactericidal activity from platelets as a function of degree of platelet 
aggregation by collagen. Upper panel, aggregometer tracing after addition of: A, collagen, 0.4 
mg; B, collagen, 0.1  rag; C, collagen, 0.01 rag; and  D, collagen, 0.1  mg after imipramine 
(1.25 mg/ml). Lower panel,  bacterial  killing by supernatant plasma after aggregation and 
sedimentation of platelets. 
gometer for three concentrations of collagen and for collagen in the presence of 
the  inhibitor, imipramine. The greater  the protein concentration of  collagen 
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Fig. 4 shows the bactericidal activity released into supernatant plasma at the 
end of the aggregation reaction. The degree of bactericidal activity similarly 
corresponded to the collagen concentration and to the degree of platelet aggre- 
gation. When collagen-induced platelet  aggregation was inhibited by imipra- 
mine,  the release of bactericidal activity was no greater than the activity in 
60 
40 
20 
A 
B 
Platelet aggregation 
100 --  Bactericidal activity 
8O 
.~  40 
E  40 
20 
o  I  I  I  I 
h5  l:lO  1:20  1:40  1:80 
Dilution of supernatant  plasma 
FIG.  5.  Effect  of  adenosine  diphosphate-induced  p]atelet  aggregation  on  release  of 
bactericidal activity. Upper panel, platelet aggregation by: A, 2 X 10  -6 M  ADP, and B, 5 X 
10  -7 M ADP  (reversible aggregation). Lower panel, bactericidal activity  of supernatant 
plasmas after aggregation and sedimentation of platelets. 
platelet-poor plasma alone. Release of bactericidal activity, therefore, closely 
paralleled  platelet  aggregation  by  collagen.  Adenosine  diphosphate~induced 
platelet aggregation was associated with only minimal release of the bactericidal 
activity into the supernatant (Fig. 5). At a low concentration, ADP produced 
reversible platelet aggregation which was not associated with significant release 
of  bactericidal  activity.  Thrombin-induced  aggregation  of  washed  platelets 
released bactericidal activity similar to that released by collagen. 1124  NABIIIT  PLATELET  BACTERICIDAL  PROTEIN 
Purification  of Bactericidal  MateriaL--The  rabbit  platelet  acid  extract  was 
partially purified by chromatography  on DEAE  cellulose (Fig. 6). Bactericidal 
activity was confined to a  small protein peak which was not retarded.  The re- 
Colony  count ~  @  @  00  @ 
o.2 
aCI gradient  0.1 
o  //  ~-,  I  JI  I  \] 
0  10  20  30  40  50 
Fraction number 
FIG.  6.  Partial purification of rabbit platelet acid extract by chromatography on DEAE 
cellulose.  Bactericidal activity depicted by Petri dishes confined  to early protein peak. Acryl- 
amide gel electrophoresis reveals two protein bands. 
TABLE VI 
Antiheparin  Activity  of Different ]~latdet Protein Fractions* 
Platelet fraction added  Thrombin clotting time 
None (saline) 
None (saline) 
Rabbit platelet acid extract, 15 #g 
Bactericidal fraction from DEAE column, 10 #g 
20% ethanol precipitate of RPAE, 2 #g 
RPAE after removal of 20% ethanol precipitate, 15/~g 
Platelet factor 4, 12/zg 
PF 4-depleted RPAE 
Sec 
15  (no heparin) 
49  (0.2 units heparin/ml) 
22 
18 
21 
52 
15 
49 
* Antiheparin activity was tested by adding fractions to a thrombin clotting time system 
in which clotting time in seconds was prolonged by addition of heparin sufficient to yield three 
times baseline clotting time (seconds).  The test system consisted of 0.3  ml fresh rabbit ci- 
trated, platelet-poor plasma, 0.1  ml test material, and 0.1  ml of heparin  (0.2 units/ml); 0.1 
ml thrombin  (10  units/ml)  was  added  as  the  stopwatch  was  started.  All materials were 
incubated at 37°C and all tests were performed in duplicate. 
mainder of the protein, which was eluted with a  gradient of NaC1, had no anti- 
bacterial  activity nor  did  it  alter  the  activity of  the  bactericidal  peak  when 
recombined with the latter.  Cationic aerylamide gel electrophoresis of the bac- 
tericidal peak revealed two protein bands. 
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out using Sephadex G-75.  Two peaks were detected, of approximately 40,000 
and 10,000 tool wt. Both of these peaks demonstrated bactericidal activity. 
Antiheparin  Activity  and Rabbit Platelet Acid Extract.--The rabbit platelet 
acid extract demonstrated antiheparin activity similar to that of platelet factor 
4 when tested in a thrombin clotting time system (Table VI). That is, RPAE 
added to a mixture of fresh plasma and heparin counteracted the prolongation 
of thrombin  time produced by heparin.  The bactericidal peak from DEAE 
cellulose  chromatography of RPAE also possessed antiheparin activity. Plate- 
let factor 4, prepared directly from washed rabbit platelets, demonstrated two 
Heparin 
inhibition  0  0  70%  0  0 
Colony count 0  0  0  0  0 
0.3  m 
dx 
E  0.2  -  [~ 
¢,j 
0,1  - 
o  l  ] 
3  6  9  12  15 
Fraction number 
FIO.  7.  Sephadex G-75 gel filtration of bactericidal protein peak from DEAE cellulose 
chromatography. Separation of bactericidal and platelet factor 4 activities. 
to three times as much antiheparin activity per microgram of protein as did 
the RPAE preparations. 
Separation of the platelet factor 4 activity from the bactericidal activity of 
the RPAE was achieved by several methods. Separation of the two activities 
was first accomplished by ethanol precipitation. The fraction of RPAE pre- 
cipitated by 20 % (v/v) ethanol demonstrated antiheparin activity (Table VI). 
This fraction was also bactericidal. However, the residual portion of the RPAE 
not precipitated by 20 % ethanol was equally bactericidal but lacked antihepa- 
rin activity. Zinc acetate precipitation was used to deplete the RPAE of platelet 
factor 4 (PF 4). The PF 4-depleted RPAE remained fully bactericidal but lost 
all antiheparin activity. Finally, separation of platelet factor 4 and bactericidal 
activities was achieved by Sephadex gel filtration of the DEAE cellulose  bac- 
tericidal peak (Fig. 7). Fig. 7 demonstrates that two peaks were eluted from the 
Sephadex gel column after application of the DEAE cellulose bactericidal peak. 
The fraction of tool wt 10,000 possessed antiheparin activity. The fraction of 
tool wt 40,000 lacked antiheparin activity. 1126  RABBIT  PLATELET  BACTERICIDAL  PROTEIN 
Platelet factor 4,  prepared  according to  the method of Niewiarowski, was 
moderately bactericidal to B. subtilis,  but required a protein concentration of 
30 #g/ml or greater for significant bactericidal effect, whereas an acid extract 
of the platelet residue after removal of PF 4,  entirely lacking in antiheparin 
activity, was strongly bacteridical. 
DISCUSSION 
These  studies  demonstrate  that  the  heat-stable  antibacterial  activity  of 
rabbit serum not only is platelet dependent, but resides preformed within the 
platelets  as  one  or  more  cationic protein  constituents  of platelet lysosomal 
granules. The platelet bactericidal proteins bear significant resemblance to the 
antibacterial proteins found in blood leukocytes by virtue of their cellular lo- 
calization in granules, heat stability, absence of dependence on serum comple- 
ment, positive charge, and inactivation bv anionic materials. Whereas leuko- 
cyte bactericidal proteins are released into intracellular vacuoles during phago- 
cytosis,  the  platelet  bactericidal  proteins  are  released  into  the  bloodstream 
during platelet aggregation and during blood coagulation. 
Characterization of the platelet bactericidal protein fraction by ion exchange 
chromatography and gel filtration has revealed a low molecular weight protein 
ot strongly positive charge which appears distinct from the antiheparin factor, 
platelet factor 4. This protein is much less stable than platelet factor 4 under 
conditions of low ionic strength and alkaline pH. In these characteristics the 
platelet bactericidal protein also closely resembles  the leukocyte bactericidal 
proteins. 
The crucial mechanism in the development of serum antibacterial activity 
against Gram-positive microorganisms is the platelet aggregation which occurs 
concomitantly with blood coagulation, rather than coagulation per se.  Blood 
coagulation involves the cctivation and cascading interaction of a series of pro- 
tein precursors present in the blood plasma; platelets normally play a catalytic 
role by providing a specialized surface (platelet factor 3) which accelerates this 
series of fluid-phase reactions to form a blood clot. Coagulation may, however, 
occur normally in the presence of severe thrombocytopenia. During injury to a 
blood vessel, exposure of subendothelial collagen acts as an initiator both to 
coagulation and to the aggregation of platelets so that the two processes nor- 
mally occur  together  (16).  Platelet aggregation may take place  quite  inde- 
pendently of blood clotting. In vitro, evidence that the release of antibacterial 
activity depends only upon platelet aggregation and not on coagulation is de- 
rived from the observations that (a) washed platelets suspended in saline release 
bactericidal protein upon aggregation in the absence of plasma; (b) the coagula- 
tion of platelet-free plasma does not yield bactericidal activity in the serum 
produced; and  (c)  platelet aggregation in anticoagulated platelet-rich plasma 
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The studies reported here suggest that the release of bactericidal activity 
from platelets requires irreversible platelet aggregation by surface active agents. 
Thus collagen and thrombin but not small doses of ADP produce release of 
bactericidal activity. It would appear that both aggregation and the platelet 
release reaction involving platelet degranulation are prerequisites for liberation 
of bactericidal proteins. This is supported by the data showing that the amount 
of bactericidal activity released  is  directly related  to  the  degree  of platelet 
aggregation produced by collagen, a surface-active aggregating agent (Fig. 4). 
Inhibitors of platelet aggregation effectively block the release of bactericidal 
activity into the supernatant  (Figs. 3  and 4).  The minimal effect of ADP- 
induced aggregation in releasing bactericidal activity also supports the concept 
that this granule-bound component only leaves the platelet under conditions of 
profound platelet disruption, for rabbit platelets exhibit only reversible aggre- 
gation on exposure to ADP (17). 
The relationship between the platelet bactericidal protein and platelet factor 
4 (PF 4) is a close one. PF 4 is a low molecular weight, positively charged pro- 
tein which possesses  marked antiheparin activity. It is released by saline ex- 
traction of frozen-thawed platelets and by platelet aggregation. It is stable to 
heating and to storage and is precipitable by zinc ions. No previous assay of 
PF 4 for antibacterial activity has been reported. We have found that PF 4 
has a modest bactericidal effect on B. subtilis at high protein concentrations. 
The crude rabbit platelet acid extract possessed  PF 4 activity. However, after 
precipitation of PF 4 with zinc ions, the platelet acid extract retained strong 
bactericidal activity. Conversely the platelet residue after extraction of PF 4 
possessed antibacterial activity which was acid extractable. This suggests that 
crude rabbit platelet acid extract contained a different and more potent bac- 
tericidal material as well as PF 4.  Both activities appeared  together in the 
cationic bactericidal peak on DEAE  cellulose,  as might be expected for two 
basic proteins. The two activities were separable by gel filtration on Sephadex. 
Many positively charged proteins and peptides have been reported to demon- 
strate antibacterial activity, and this may account for the bactericidal activity 
associated with PF 4. However, the data reported here indicate that the lysoso- 
real bactericidal protein of platelets is indeed separable from platelet factor 4. 
The bactericidal effect of the rabbit platelet cationic protein suggests that 
the bacteria need to be metabolically active. This is indicated by the greater 
killing effect at 37°C  than at lower temperatures, and by a more rapid effect 
on rapidly growing organisms than on bacteria in the stationary growth phase. 
Bacteria exposed in the cold remove the bactericidal potency of the platelet 
extract yet are not killed, suggesting that adsorption of the protein onto the 
negatively charged bacterial surface may not completely explain the bactericidal 
effect. Basic proteins easily adsorb to negatively charged surfaces, even to the 
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only certain of such adsorbable proteins alter the cation permeability of such 
particles. Previous studies suggest that basic proteins may act as metabolic in- 
hibitors or may alter membrane permeability. Amano et al. (19) demonstrated 
that plakin,  a  water  extract  of horse platelets,  caused marked inhibition of 
oxygen uptake by susceptible aerobic bacteria. Zeya and Spitznagel (7) showed 
similar inhibition of oxygen consumption by bacteria exposed to cationic pro- 
teins prepared  from rabbit  leukocyte granules. They demonstrated that the 
bacteria underwent changes in cell permeability and correlated leakage of nu- 
cleotide  components  with  bacterial  killing  after  incubation  with  leukocyte 
cationic proteins.  The sensitivity of rapidly growing B.  subtilis  to killing by 
platelet cationic protein, and the similarity of this platelet factor to the cationic 
proteins of leukocyte granules, strongly suggests that the bactericidal mech- 
anism may similarly involve alterations in permeability and oxidative metabo- 
lism. 
What is  the  possible  physiological role  for a  platelet-derived  bactericidal 
substance? Different species of animals vary widely in serum beta lysin activity. 
Cationic extracts of normal human platelets demonstrate no bactericidal activ- 
ity. Whether human platelets can develop such activity as part of the inflam- 
matory response has not been determined. Many foreign particles and materials 
which may gain access to the bloodstream during infection or tissue injury are 
capable of producing platelet aggregation (20). 
Local intravascular aggregation of platelets by appropriate circulating stim- 
uli, such as bacteria, bacterial products such as endotoxin, or antigen-antibody 
complexes,  may initiate the  release  of bactericidal platelet protein  into  the 
blood. Hunder and Jacox demonstrated that rabbits given intraperitoneal in- 
jections of endotoxin developed an increased level of serum bactericidal activ- 
ity (4). Des Preset al. showed that incubation of rabbit platelet-rich plasma 
with endotoxin released bactericidal activity (21). Recently, Clawson and White 
reported the aggregation of platelets by bacteria  (22).  The release of locally 
high concentrations of platelet bactericidal protein may permit killing of sus- 
ceptible bacteria trapped in the platelet aggregates. The question whether sub- 
sequent ingestion of platelet-bacterial clumps by polymorphonuclear leukocytes 
is facilitated by the release of platelet constituents in the aggregates, coating 
the bacteria, remains to be answered. 
These observations suggest that the platelet, like the leukocyte, is capable 
of participating in the development of the inflammatory response in a variety 
of ways. Platelet constituents released after interaction of platelets with in- 
flammatory stimuli include nucleotides, vasoactive amines, antiheparin factor, 
and cationic proteins possessfing permeability-enhancing and bactericidal ca- 
pacity. These factors may be present in relatively high concentrations in the 
vicinity of the platelet aggregate at the vascular endothelial surface. Their role 
in affecting or altering that surface remains to be explored. ]3.  B.  WEKSLER AND R.  L.  NACItMAN  1129 
SUMMARY 
The heat-stable antibacterial activity of rabbit serum against Gram-positive 
microorganisms has been shown to reside in a cationic protein fraction of plate- 
let lysosomal granules. The activity is released during platelet aggregation. No 
plasma or serum component is required for the bactericidal effect. The platelet 
bactericidin resembles the antibacterial proteins of leukocyte granules both in 
cellular localization and in biochemical characteristics. It can be differentiated 
from platelet factor 4,  the antiheparin factor, which is also a  basic protein in 
platelet  granules. The antibacterial  effect of the platelet bactericidin may be 
related to the metabolic activity of the organisms. This antibacterial activity 
of platelets may represent another means by which platelets can participate in 
host inflammatory defense reactions. 
The authors thank Miss Jean Esposito for excellent technical assistance. 
REFERENCES 
1.  Fodor,  J.  1887. Die Faghigkeit  des Blutes  Bakterien  zu vernichten.  Deut. Med. 
Wochenschr. 13:745. Cited  in Skarnes, R. C., and D. W. Watson.  1957. Anti- 
microbial factors of normal tissues and fluids. Bacteriol. Rev. 21:273. 
2.  Gengou, O. 1901. De l'origine de l'axenine de serums normaux. Ann. Inst. Pasteur 
(Paris). 16:232. 
3.  Hirsch, J. G. 1960. Comparative bactericidal activities of blood serum and plasma 
serum. J. Exp. Med. 112:15. 
4.  Hunder,  G.,  and R.  F. Jacox.  1963. Experimentally  induced  alterations  of the 
bactericidal  property of rabbit serum for Bacillus subtilis. J. Bacteriol. 90:540. 
5. Jago, R., and R. F. Jacox.  1961. Cellular source and character of a heat stable 
bactericidal  property associated  with rabbit and rat platelets.  J. Exp.  Med. 
113:701. 
6.  Myrvik, Q. N., and E. S. Leake.  1960. Studies on antibacterial  factors  in mam- 
malian tissues and fluids. IV. Demonstration of two nondialyzable components 
in the serum bactericidin  system for Bacillus subtiIis. Y. Immunol. 84:247. 
7.  Zeya, H. I., and J. K. Spitznagel.  1966. Cationic proteins  of polymorphonuclear 
leukocyte  lysosomes.  II.  Composition,  properties  and  mechanisms  of  anti- 
bacterial  action. J. Bacteriol. 91:755. 
8.  Janoff, A., and B. W. Zweifach. 1964. Production of inflammatory  changes in the 
microcirculation  by cationic proteins  extracted  from lysosomes. J. Exp. Med. 
120:747. 
9.  Nachman, R., B. Weksler, and B. Ferris.  1970. Increased vascular  permeability 
produced by human platelet  granule cationic extract.  J. Clin. Invest. 49:274. 
10.  Marcus, A. J., D. Zueker-Franklin,  L. B. Sailer, and H. L. Ullman.  1966. Studies 
on human platelet  granules and membranes. J. Clin. Invest. 46:580. 
11.  Rubin, A. L., M. P. Drake,  P. F. Davison, D. Pfahl,  P. T. Speakman,  and F. O. 
Schmitt.  1965. Effect  of pepsin  treatment  on  the  interaction  properties  of 
tropocollagen macromolecules. Biochemistry. 4:181. 1130  RABBIT  PLATELET  BACTER~IDAL  PROTEIN 
12.  Poplawski,  A., and S. Niewiarowski.  1965. Method for determining antiheparin 
activity of platelets and erythrocytes. Thromb. Diath.  IIaemorrh.  13"149. 
13.  Niewiarowski,  S.,  R. Farbiszewski,  and A. Poplawski.  1965. Studies  on platelet 
factor 2  (PF 2-fibrinogen activating factor)  and platelet factor 4  (PF 4-anti- 
heparin factor).  In Biochemistry of the Blood Platelets.  E. Kowalski and  S. 
Niewiarowski, editors. Academic Press, Inc., New York. 35. 
14.  Reisfeld,  R. A.,  U. J.  Lewis,  and  O.  E. Williams.  1962. Disc electrophoresis of 
basic proteins and peptides on polyacrylamide gels. Nature (London).  195:281. 
15.  Bailey,  J.  L.,  S.  Moore,  and  W.  H.  Stein.  1956. Peptides  obtained  by peptic 
hydrolysis of performic acid-oxidized ribonuclease. J. Biol. Chem. 221:143. 
16.  Marcus, A., and M. B. Zucker.  1965. The Physiology of Blood Platelets.  Grune 
and Stratton Inc. New York. 
17.  Kimelberg, H. K., and D. Papahadjopoulos.  1971. Interactions of basic proteins 
with phospholipid membranes. J. Biol. Chem. 246:1142. 
18.  Mills, D. C. B. 1969. Platelet aggregation. In Biologic Basis of Medicine. Academic 
Press, Inc., New York. 3:163. 
19.  Amano, T., K. Kato, and R. Shimizu.  1952. Studies on the role of plakin. Med. 
J. Osaka Univ. 3:293. 
20.  Mustard, J. F., and M. A. Packham. 1970. Factors influencing platelet function: 
adhesion, release  and aggregation. Pharmacol. Rev. 22:97. 
21.  Des Prez, R., H. I. Horowitz, and E. W. Hook. 1961. Effects of bacterial endotoxin 
on rabbit  platelets.  I.  Platelet  aggregation and  release  of platelet  factors in 
vitro. J. Exp. Med. 114:857. 
22.  Clawson, C.  C., and J.  G. White.  1970. Sequestration and killing  of bacteria by 
human platelets. Blood J. Hematol. 36:843. 